Iraq Roche Partnership to Enhance Healthcare Services

By João L. Carapinha

October 13, 2024

The article from Shafaq News highlights the renewal of the strategic Iraq Roche Partnership. This important renewal took place on September 3, 2024, following a successful year of collaboration aimed at enhancing healthcare services in Iraq.

Renewal of Partnership

The Iraqi Ministry of Health announced the renewal of its strategic partnership with Roche. This agreement aims to build on the success achieved over the past year, particularly in improving healthcare delivery across the nation.

Objectives and Initiatives

The partnership focuses on several key objectives:

  • Digital Transformation: The agreement emphasizes developing national digital tools and solutions. These innovations will improve decision-making and deliver data-driven healthcare. This initiative is a crucial part of the Ministry’s broader efforts to advance the healthcare sector through digital transformation.
  • Educational Initiatives: The partnership will continue supporting educational programs. These initiatives aim to raise awareness about early disease detection. It is vital for enhancing treatment outcomes and lessening the severity of health conditions.

Commitments and Support

  • Roche’s Commitment: Roche has confirmed its dedication to supporting the Iraqi Ministry of Health with its expertise and resources. Ayman Haj Ibrahim, Roche’s manager in Iraq, emphasized the company’s commitment to providing comprehensive care solutions for Iraqi patients.
  • Ministry’s Perspective: Iraqi Health Minister and Director General of the State Company for Marketing Drugs and Medical Appliances (Kimadia), expressed their approval. They highlighted the Ministry’s effort to develop Iraq’s healthcare sector using global expertise to meet international standards.

Signing of the Agreement

The contract renewal was signed by Dr. Ahmed Sami on behalf of the Ministry of Health and Dr. Ayman Haj Ibrahim for Roche.

Overall, the renewed strategic partnership is seen as a pivotal step towards improving healthcare services in Iraq. This collaboration leverages Roche’s global expertise and resources to drive digital transformation, enhance diagnostic capabilities, and elevate health outcomes for Iraqi citizens.

Reference url

Recent Posts

Portugal Cannabis Market Decline: Analyzing the Impact of Licensing Reductions

By João L. Carapinha

May 15, 2026

The Portugal cannabis market decline has accelerated sharply since January 2026. Official Infarmed IP lists show that more than 30 percent of entities authorised for medicinal cannabis activities in Portugal have been suspended or permanently removed, producing a measurable contraction across cul...
Boosting Africa Vaccine Manufacturing: A New Era of Local Production and Supply Security

By João L. Carapinha

Africa Vaccine Manufacturing stands to benefit from ongoing talks between Africa CDC and Aspen Pharmacare aimed at securing long-term vaccine supply agreements that strengthen local production capacity across the continent. The discussions focus on selecting priority antigens, scaling annual outp...
NICE Approves Durvalumab for Gastric Cancer Treatment

By HEOR Staff Writer

NICE has issued final draft guidance recommending durvalumab, within its marketing authorisation, for use with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) chemotherapy as neoadjuvant and adjuvant treatment, followed by durvalumab monotherapy as adjuvant treatment, in adults with ...